P. V. Borne

发表

Donor T-cell responses and disease progression patterns of multiple myeloma

H. Putter, H. Veelken, J. Schetelig, 2017, Bone Marrow Transplantation.

Molecular persistence of chronic myeloid leukemia caused by donor T cells specific for lineage-restricted maturation antigens not recognizing immature progenitor-cells

M. Heemskerk, R. Willemze, A. Mulder, 2006, Leukemia.

A new time-dependent approach for assessment of the impact of invasive aspergillosis shows effect on short- but not on long-term survival of patients with AML or high-risk MDS

S. Cessie, P. V. Borne, M. D. Boer, 2017, Bone Marrow Transplantation.

Effect of genetic polymorphisms in genes encoding GST isoenzymes on BU pharmacokinetics in adult patients undergoing hematopoietic SCT

J. Hartigh, J. Zwaveling, T. Straaten, 2012, Bone Marrow Transplantation.

Inferior Outcome of Addition of the Aminopeptidase Inhibitor Tosedostat to Standard Intensive Treatment for Elderly Patients with AML and High Risk MDS

E. Vellenga, M. Jongen‐Lavrencic, M. Vekemans, 2021, Cancers.

Comparison of conditioning regimens of various intensities for allogeneic hematopoietic SCT using HLA-identical sibling donors in AML and MDS with <10% BM blasts: a report from EBMT

N. Kröger, M. Robin, T. Witte, 2013, Bone Marrow Transplantation.

Myeloablative T cell-depleted alloSCT with early sequential prophylactic donor lymphocyte infusion is an efficient and safe post-remission treatment for adult ALL

R. Willemze, H. Veelken, S. Kersting, 2014, Bone Marrow Transplantation.

Myeloablative T cell-depleted alloSCT with early sequential prophylactic donor lymphocyte infusion is an efficient and safe post-remission treatment for adult ALL

R. Willemze, H. Veelken, S. Kersting, 2014, Bone Marrow Transplantation.

Donor lymphocyte infusions for the treatment of chronic myeloid leukemia relapse following peripheral blood or bone marrow stem cell transplantation

W. Wiktor-Jedrzejczak, T. Witte, G. Gurman, 2013, Bone Marrow Transplantation.

Predictive impact of allele-matching and EBMT risk score for outcome after T-cell depleted unrelated donor transplantation in poor-risk acute leukemia and myelodysplasia

R. Willemze, B. Löwenberg, J. Cornelissen, 2011, Leukemia.

PCR-based detection of Aspergillus fumigatus Cyp51A mutations on bronchoalveolar lavage: a multicentre validation of the AsperGenius assay® in 201 patients with haematological disease suspected for invasive aspergillosis.

J. Cornelissen, J. Boelens, A. Vonk, 2016, The Journal of antimicrobial chemotherapy.

Joint models quantify associations between immune cell kinetics and allo-immunological events after allogeneic stem cell transplantation and subsequent donor lymphocyte infusion

H. Veelken, E. Koster, P. V. Borne, 2023, Frontiers in immunology.

Outcomes after myeloablative unrelated donor stem cell transplantation using both in vitro and in vivo T-cell depletion with alemtuzumab.

J. Falkenburg, G. Hale, W. Fibbe, 2006, Haematologica.

Risk of sinusoidal obstruction syndrome in allogeneic stem cell transplantation after prior gemtuzumab ozogamicin treatment: a retrospective study from the Acute Leukemia Working Party of the EBMT

R. Fanin, M. Labopin, D. Blaise, 2017, Bone Marrow Transplantation.

Risk factors for graft-versus-host-disease after donor lymphocyte infusion following T-cell depleted allogeneic stem cell transplantation

L. Wreede, E. Koster, C. Halkes, 2024, Frontiers in immunology.